Literature DB >> 23466484

New perspectives of curcumin in cancer prevention.

Wungki Park1, A R M Ruhul Amin, Zhuo Georgia Chen, Dong M Shin.   

Abstract

Numerous natural compounds have been extensively investigated for their potential for cancer prevention over the decades. Curcumin, from Curcuma longa, is a highly promising natural compound that can be potentially used for chemoprevention of multiple cancers. Curcumin modulates multiple molecular pathways involved in the lengthy carcinogenesis process to exert its chemopreventive effects through several mechanisms: promoting apoptosis, inhibiting survival signals, scavenging reactive oxidative species (ROS), and reducing the inflammatory cancer microenvironment. Curcumin fulfills the characteristics for an ideal chemopreventive agent with its low toxicity, affordability, and easy accessibility. Nonetheless, the clinical application of curcumin is currently compromised by its poor bioavailability. Here, we review the potential of curcumin in cancer prevention, its molecular targets, and mechanisms of action. Finally, we suggest specific recommendations to improve its efficacy and bioavailability for clinical applications.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23466484      PMCID: PMC3693758          DOI: 10.1158/1940-6207.CAPR-12-0410

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  100 in total

1.  Recent advances in head and neck cancer.

Authors:  Robert I Haddad; Dong M Shin
Journal:  N Engl J Med       Date:  2008-09-11       Impact factor: 91.245

2.  Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles.

Authors:  Jinghua Duan; Yangde Zhang; Shiwei Han; Yuxiang Chen; Bo Li; Mingmei Liao; Wei Chen; Xingming Deng; Jinfeng Zhao; Boyun Huang
Journal:  Int J Pharm       Date:  2010-09-08       Impact factor: 5.875

3.  Chemoprevention of colon cancer by a synthetic curcumin analog involves amelioration of oxidative stress.

Authors:  T Devasena; V P Menon Venugopal; K N Rajasekaran
Journal:  Toxicol Mech Methods       Date:  2005       Impact factor: 2.987

4.  Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts.

Authors:  Sankar Bhattacharyya; Dewan Md Sakib Hossain; Suchismita Mohanty; Gouri Sankar Sen; Sreya Chattopadhyay; Shuvomoy Banerjee; Juni Chakraborty; Kaushik Das; Diptendra Sarkar; Tanya Das; Gaurisankar Sa
Journal:  Cell Mol Immunol       Date:  2010-03-22       Impact factor: 11.530

5.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

6.  Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB.

Authors:  Beatrice E Bachmeier; Isabelle V Mohrenz; Valentina Mirisola; Erwin Schleicher; Francesco Romeo; Clara Höhneke; Marianne Jochum; Andreas G Nerlich; Ulrich Pfeffer
Journal:  Carcinogenesis       Date:  2007-11-13       Impact factor: 4.944

7.  First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial.

Authors:  J Cuzick; J Forbes; R Edwards; M Baum; S Cawthorn; A Coates; A Hamed; A Howell; T Powles
Journal:  Lancet       Date:  2002-09-14       Impact factor: 79.321

Review 8.  Modulation of transcription factors by curcumin.

Authors:  Shishir Shishodia; Tulika Singh; Madan M Chaturvedi
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

9.  Identification of ErbB-2 kinase domain motifs required for geldanamycin-induced degradation.

Authors:  Oleg Tikhomirov; Graham Carpenter
Journal:  Cancer Res       Date:  2003-01-01       Impact factor: 12.701

10.  Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis.

Authors:  S M Lippman; J G Batsakis; B B Toth; R S Weber; J J Lee; J W Martin; G L Hays; H Goepfert; W K Hong
Journal:  N Engl J Med       Date:  1993-01-07       Impact factor: 91.245

View more
  70 in total

Review 1.  Nutrient-Gene Interaction in Colon Cancer, from the Membrane to Cellular Physiology.

Authors:  Tim Y Hou; Laurie A Davidson; Eunjoo Kim; Yang-Yi Fan; Natividad R Fuentes; Karen Triff; Robert S Chapkin
Journal:  Annu Rev Nutr       Date:  2016-07-17       Impact factor: 11.848

2.  Mechanisms of colitis-accelerated colon carcinogenesis and its prevention with the combination of aspirin and curcumin: Transcriptomic analysis using RNA-seq.

Authors:  Yue Guo; Zheng-Yuan Su; Chengyue Zhang; John M Gaspar; Rui Wang; Ronald P Hart; Michael P Verzi; Ah-Ng Tony Kong
Journal:  Biochem Pharmacol       Date:  2017-03-04       Impact factor: 5.858

3.  Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer.

Authors:  Jens U Marquardt; Luis Gomez-Quiroz; Lucrecia O Arreguin Camacho; Federico Pinna; Yun-Han Lee; Mitsuteru Kitade; Mayrel Palestino Domínguez; Darko Castven; Kai Breuhahn; Elizabeth A Conner; Peter R Galle; Jesper B Andersen; Valentina M Factor; Snorri S Thorgeirsson
Journal:  J Hepatol       Date:  2015-05-01       Impact factor: 25.083

Review 4.  Degradation of Curcumin: From Mechanism to Biological Implications.

Authors:  Claus Schneider; Odaine N Gordon; Rebecca L Edwards; Paula B Luis
Journal:  J Agric Food Chem       Date:  2015-04-02       Impact factor: 5.279

5.  Preclinical In Vitro, In Vivo, and Pharmacokinetic Evaluations of FLLL12 for the Prevention and Treatment of Head and Neck Cancers.

Authors:  Abu Syed Md Anisuzzaman; Abedul Haque; Mohammad Aminur Rahman; Dongsheng Wang; James R Fuchs; Selwyn Hurwitz; Yuan Liu; Gabriel Sica; Fadlo R Khuri; Zhuo Georgia Chen; Dong M Shin; A R M Ruhul Amin
Journal:  Cancer Prev Res (Phila)       Date:  2015-10-28

Review 6.  Interacting inflammatory and growth factor signals underlie the obesity-cancer link.

Authors:  Laura M Lashinger; Nikki A Ford; Stephen D Hursting
Journal:  J Nutr       Date:  2013-11-27       Impact factor: 4.798

Review 7.  The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome.

Authors:  Yiwei Li; Vay Liang W Go; Fazlul H Sarkar
Journal:  Pancreas       Date:  2015-01       Impact factor: 3.327

8.  FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway.

Authors:  Abedul Haque; Mohammad A Rahman; James R Fuchs; Zhuo Georgia Chen; Fadlo R Khuri; Dong M Shin; A R M Ruhul Amin
Journal:  Cancer Lett       Date:  2015-04-24       Impact factor: 8.679

9.  MiR-21 suppresses the anticancer activities of curcumin by targeting PTEN gene in human non-small cell lung cancer A549 cells.

Authors:  W Zhang; W Bai; W Zhang
Journal:  Clin Transl Oncol       Date:  2013-11-29       Impact factor: 3.405

Review 10.  Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases.

Authors:  Avijit Sarkar; Ronita De; Asish K Mukhopadhyay
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.